HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DENG, W.-G. Articles by WU, K. K. Search for Related Content PubMed PubMed Citation Articles by DENG, W.-G. Articles by WU, K. K.

Aspirin and salicylate bind to immunoglobulin heavy chain binding protein (BiP) and inhibit its ATPase activity in human fibroblasts

Vascular Biology Research Center and Division of Hematology, Department of Internal Medicine, University of Texas-Houston Medical School, Houston, Texas 77030, USA

¹Correspondence: Vascular Biology Research Center and Division of Hematology, Department of Internal Medicine, University of Texas-Houston Medical School, 6431 Fannin MSB 5.016, Houston, TX 77030, USA. E-mail: Kenneth.K.Wu{at}uth.tmc.edu

Salicylic acid (SA), an endogenous signaling molecule of plants, possesses anti-inflammatory and anti-neoplastic actions in human. Its derivative, aspirin, is the most commonly used anti-inflammatory and analgesic drug. Aspirin and sodium salicylate (salicylates) have been reported to have multiple pharmacological actions. However, it is unclear whether they bind to a cellular protein. Here, we report for the first time the purification from human fibroblasts of a 78 kDa salicylate binding protein with sequence identity to immunoglobulin heavy chain binding protein (BiP). The K_d values of SA binding to crude extract and to recombinant BiP were 45.2 and 54.6 µM, respectively. BiP is a chaperone protein containing a polypeptide binding site recognizing specific heptapeptide sequence and an ATP binding site. A heptapeptide with the specific sequence displaced SA binding in a concentration-dependent manner whereas a control heptapeptide did not. Salicylates inhibited ATPase activity stimulated by this specific heptapeptide but did not block ATP binding or induce BiP expression. These results indicate that salicylates bind specifically to the polypeptide binding site of BiP in human cells that may interfere with folding and transport of proteins important in inflammation.—Deng, W.-G., Ruan, K.-H., Du, M., Saunders, M. A., Wu, K. K. Aspirin and salicylate bind to immunoglobulin heavy chain binding protein (BiP) and inhibit its ATPase activity in human fibroblasts.

Key Words: salicylate binding protein • SA • COX-2 • acetylsalicylic acid

This article has been cited by other articles:

				P. Pyrko, A. H. Schonthal, F. M. Hofman, T. C. Chen, and A. S. Lee The Unfolded Protein Response Regulator GRP78/BiP as a Novel Target for Increasing Chemosensitivity in Malignant Gliomas Cancer Res., October 15, 2007; 67(20): 9809 - 9816. [Abstract] [Full Text] [PDF]

				A. S. Lee GRP78 Induction in Cancer: Therapeutic and Prognostic Implications Cancer Res., April 15, 2007; 67(8): 3496 - 3499. [Abstract] [Full Text] [PDF]

				A. M. Silva, D. Wang, A. A. Komar, B. A. Castilho, and B. R. G. Williams Salicylates Trigger Protein Synthesis Inhibition in a Protein Kinase R-like Endoplasmic Reticulum Kinase-dependent Manner J. Biol. Chem., April 6, 2007; 282(14): 10164 - 10171. [Abstract] [Full Text] [PDF]

				K. A. Cieslik, Y. Zhu, M. Shtivelband, and K. K. Wu Inhibition of p90 Ribosomal S6 Kinase-mediated CCAAT/Enhancer-binding Protein {beta} Activation and Cyclooxygenase-2 Expression by Salicylate J. Biol. Chem., May 6, 2005; 280(18): 18411 - 18417. [Abstract] [Full Text] [PDF]